7 Major Trends Shaping the Health Care Industry: Insights for Investors, Consultants and Marketing Professionals in 2024

Credit iStock

11.25.24

As the health care industry continues its rapid evolution, a deep understanding of emerging trends is essential for investors, consultants, and marketing professionals. From skyrocketing costs to groundbreaking technologies, the sector is undergoing a transformation that offers both opportunities and challenges. This blog post summarizes the key trends in the health care landscape, leveraging insights from recent research and industry data.

Check out our Health Care Industry Market Research center!

Plunkett’s Health Care Industry eBook, latest edition.

1. Rising Health Care Costs: A Growing Financial Burden

Health care spending in the U.S. continues to rise at an alarming rate. In 2024, U.S. health care expenditures are projected to reach $5.05 trillion, up from $4.66 trillion in 2023. This staggering growth is driven by an aging population, the increasing cost of new technologies, and the continued rise in prescription drug prices. Investors should be aware that health care expenses, now constituting about 17.7% of the U.S. GDP, are crowding out investments in other critical areas such as infrastructure and education.

One of the key drivers of these cost increases is the aging baby boomer population. As more individuals hit retirement age, their demand for health services, particularly Medicare, is growing. This trend is expected to persist as the number of Medicare beneficiaries rises from 66.6 million in 2023 to over 80 million by 2034.

2. Consolidation and Growth of Health Systems

Another major shift is the consolidation of health care providers. The passage of the Affordable Care Act (ACA) accelerated hospital mergers and the creation of Accountable Care Organizations (ACOs). Large hospital chains have gained substantial market share, improving their negotiating power with insurers and suppliers. However, this consolidation has also led to reduced competition, which can drive up prices for patients.

The ACA’s push toward integrated care systems incentivizes the formation of ACOs, which are networks of doctors and hospitals that take a coordinated approach to patient care. ACOs that meet quality and cost targets are rewarded financially, promoting more efficient care delivery. This consolidation trend is a double-edged sword for investors. On the one hand, larger systems may offer operational efficiencies, but they also face regulatory scrutiny and potential antitrust actions.

3. Technological Advancements: Telemedicine, AI, and Genomics

Health care technology is advancing rapidly, offering new opportunities for innovation and cost reduction. The acceleration of electronic health records (EHR), telemedicine, and remote patient monitoring has been transformative. The COVID-19 pandemic boosted the adoption of telemedicine, and the trend continues as patients seek more convenient care options.

Moreover, artificial intelligence (AI), deep learning, and machine learning are finding commercial applications in diagnostics, personalized treatment plans, and robotic surgery. AI’s ability to process vast amounts of health data allows for more accurate diagnoses and more efficient use of resources.

In genomics, the cost of sequencing a patient’s DNA has plummeted, enabling personalized medicine. Genetic profiling is increasingly used to tailor treatments to individual patients, particularly in cancer care. As the cost of these technologies decreases, they will become more accessible, driving demand for personalized health care.

4. Pharmaceutical Trends: Expensive Breakthroughs and Generic Dominance

The pharmaceutical sector is seeing both explosive growth and rising controversy. Prescription drug costs in the U.S. are expected to soar to $463 billion in 2024. Some of the most exciting developments are occurring in the biotech space, with new treatments for obesity, diabetes, and other chronic diseases showing remarkable promise. Drugs such as Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound are redefining the treatment of obesity and could lead to substantial long-term cost savings by reducing obesity-related chronic diseases.

However, these new therapies come with hefty price tags, sparking debates about the sustainability of drug pricing. Generic drugs account for the largest share of prescriptions by volume, but not by revenue. Investors in the pharmaceutical space should monitor the ongoing battle between brand-name drugs and generics, especially as U.S. government initiatives to control drug prices gain momentum.

5. The Shift Toward Value-Based Care

One of the most critical transformations in the health care industry is the shift from fee-for-service models to value-based care. Value-based care ties provider payments to patient health outcomes, promoting cost-efficient care while improving patient satisfaction. Major health insurers and Medicare are adopting this model, which could fundamentally reshape the industry.

For investors, the move toward value-based care presents both opportunities and challenges. Health care providers that can demonstrate better outcomes at lower costs stand to gain financially. However, the transition requires significant investment in data analytics, patient tracking, and care coordination.

6. Medical Tourism and Globalization of Health Care

Health care is also becoming a more globalized industry. Medical tourism, once a niche market, is growing as patients from high-cost countries like the U.S. seek care in nations where medical procedures are more affordable. Countries like India, China, and Mexico are seeing rapid growth in their health care sectors, driven by lower costs and improving care quality.

For investors, medical tourism offers potential growth in international health care markets. However, it also introduces risks related to the quality of care and the regulation of medical standards across borders.

7. Health Care’s Growing Transparency and Consumer Empowerment

Finally, the availability of online health care quality and outcomes data is revolutionizing the way consumers interact with the health care system. Patients and payers can now compare the performance of hospitals and doctors, leading to greater transparency and competition. Websites like Medicare’s Hospital Compare allow consumers to assess hospital quality and make more informed choices about their care.

This trend empowers consumers but also forces providers to improve their services or risk losing business. For marketing professionals, the growing demand for transparency presents an opportunity to showcase the strengths of health care organizations, particularly those that excel in patient satisfaction and outcomes.

Conclusion

The health care industry is undergoing profound changes that present both challenges and opportunities for investors, consultants, and marketing professionals. Rising costs, consolidation, technological innovation, pharmaceutical advancements, and the shift to value-based care are all reshaping the landscape. Understanding these trends is crucial for navigating the complexities of the health care market and capitalizing on emerging opportunities.

For investors, consultants and marketing professionals.

Key Concepts:  Biotechnology, business, healthcare, economics, healthcare, entrepreneurship, finance, hospitals, globalization, drugs, innovation, investing, marketing, pharmaceuticals, technology, robotics

Source: Plunkett Research, Ltd., Copyright © 2024